Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bad-deficient mice develop diffuse large B cell lymphoma.

Ann M Ranger1, Jiping Zha, Hisashi Harada

  • 1Howard Hughes Medical Institute and Department of Pathology, Harvard Medical School and Dana-Farber Cancer Institute, Boston, MA 02115, USA.

Proceedings of the National Academy of Sciences of the United States of America
|July 24, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Biological Function for the Neuronal Activity-Dependent Component of Bdnf Transcription in the Development of Cortical Inhibition.

Neuron·2026
Same author

Astrocyte glucocorticoid receptor signalling restricts neuronal plasticity.

Nature·2026
Same author

Proteasome inhibition enhances lysosome-mediated targeted protein degradation.

Cell death & disease·2026
Same author

Sacituzumab Govitecan as an Effective Strategy for Sensitizing Chemoresistant HNSCC Cells to Senolytic Intervention.

bioRxiv : the preprint server for biology·2026
Same author

Genomic approaches for understanding the evolution of the human brain.

Nature neuroscience·2026
Same author

Dickkopf1 is a novel endogenous ligand for priming NLRP3 inflammasome in macrophages via TLR4.

Journal of immunology (Baltimore, Md. : 1950)·2026

The proapoptotic molecule BAD (Bcl-2-associated death promoter) suppresses lymphoma development in mice. Loss of BAD leads to increased cancer incidence, particularly in lymphocytes, highlighting its tumor-suppressive role.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The BH3-only protein BAD (Bcl-2-associated death promoter) regulates apoptosis.
  • Survival factor signaling differentially controls BAD's proapoptotic activity.

Purpose of the Study:

  • To investigate the in vivo role of BAD in apoptosis and tumorigenesis.
  • To determine if BAD is essential for apoptosis induced by survival factor withdrawal.

Main Methods:

  • Generation and analysis of Bad-deficient mice (lacking BAD long and BAD short isoforms).
  • Assessment of cell development, apoptosis, lymphocyte function, and tumor incidence in Bad-null mice.
  • Evaluation of apoptosis in response to epidermal growth factor (EGF) or insulin-like growth factor I (IGF-I) withdrawal.

Related Experiment Videos

Main Results:

  • Bad-deficient mice were viable with largely normal cell development.
  • BAD acts as a sensitizing BH3-only molecule, mediating apoptosis after EGF/IGF-I withdrawal.
  • Lymphocytes showed subtle defects in proliferation and IgG production but no premalignant hyperplasia.
  • Aging Bad-null mice developed diffuse large B cell lymphoma.
  • Gamma-irradiation increased lymphoblastic leukemia/lymphoma incidence in Bad-null mice.

Conclusions:

  • Proapoptotic BAD functions as a tumor suppressor in the lymphocyte lineage.
  • BAD is crucial for mediating apoptosis in response to specific survival factor withdrawal.
  • Loss of BAD predisposes to lymphomagenesis, particularly under stress conditions like irradiation.